Molecular Partners Ag (MOLN) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to $7.13.
- Molecular Partners Ag's EPS (Weighted Average and Diluted) rose 1359.88% to $7.13 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.07, marking a year-over-year increase of 144.18%. This contributed to the annual value of -$1.81 for FY2024, which is 14.12% up from last year.
- Latest data reveals that Molecular Partners Ag reported EPS (Weighted Average and Diluted) of $7.13 as of Q3 2025, which was up 190.58% from -$7.87 recorded in Q2 2025.
- Molecular Partners Ag's 5-year EPS (Weighted Average and Diluted) high stood at $7.13 for Q3 2025, and its period low was -$9.85 during Q2 2024.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.49 (2023), whereas its average is -$0.08.
- In the last 5 years, Molecular Partners Ag's EPS (Weighted Average and Diluted) surged by 4,537.65% in 2023 and then slumped by 252.75% in 2024.
- Molecular Partners Ag's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.60 in 2021, then tumbled by 171.48% to -$1.62 in 2022, then surged by 58.23% to -$0.68 in 2023, then grew by 22.37% to -$0.53 in 2024, then surged by 1,359.88% to $7.13 in 2025.
- Its EPS (Weighted Average and Diluted) was $7.13 in Q3 2025, compared to -$7.87 in Q2 2025 and $6.34 in Q1 2025.